Leukocyte telomere length and renal cell carcinoma survival in two studies

BACKGROUND: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent. METHODS: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, l...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Callahan, Catherine L, Schwartz, Kendra, Ruterbusch, Julie J, Shuch, Brian, Graubard, Barry I, Lan, Qing, Cawthon, Richard, Baccarelli, Andrea A, Chow, Wong-Ho, Rothman, Nathaniel, Hofmann, Jonathan N, Purdue, Mark P
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2017
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572185/
https://ncbi.nlm.nih.gov/pubmed/28742796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.237
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky